nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer
|
Wang, Runchang |
|
|
25 |
5 |
p. 1425-1435 |
artikel |
2 |
Adipocytes secretome from normal and tumor breast favor breast cancer invasion by metabolic reprogramming
|
Zaoui, Maurice |
|
|
25 |
5 |
p. 1389-1401 |
artikel |
3 |
A multi-center cross-sectional investigation of the diagnosis and treatment of breast cancer with synchronous ipsilateral supraclavicular lymph node metastases based on the CSBrs-009
|
Ai, Xiang |
|
|
25 |
5 |
p. 1482-1487 |
artikel |
4 |
Axillary staging and management of cN + breast cancer patients treated with neoadjuvant chemotherapy: results of a survey among breast cancer surgeons in Spain
|
Munoz, Paula |
|
|
25 |
5 |
p. 1463-1471 |
artikel |
5 |
Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood–brain barrier and treatment strategies
|
Chhichholiya, Yogita |
|
|
25 |
5 |
p. 1218-1241 |
artikel |
6 |
Cancer secretome: finding out hidden messages in extracellular secretions
|
Padgaonkar, Mrunali |
|
|
25 |
5 |
p. 1145-1155 |
artikel |
7 |
C-Fos-activated circRPPH1 contributes to glioma stemness
|
Xu, Gang |
|
|
25 |
5 |
p. 1277-1286 |
artikel |
8 |
Construction of prediction model for prognosis of uterine corpus endometrial carcinoma based on pyroptosis gene
|
Zhang, Chunyan |
|
|
25 |
5 |
p. 1413-1424 |
artikel |
9 |
Correction to: New update to the guidelines on testing predictive biomarkers in non‑small‑cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
|
Isla, Dolores |
|
|
25 |
5 |
p. 1488 |
artikel |
10 |
Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature
|
Li, Yaqi |
|
|
25 |
5 |
p. 1315-1331 |
artikel |
11 |
CRISPR-Cas9-mediated gene therapy in lung cancer
|
Kazemizadeh, Hossein |
|
|
25 |
5 |
p. 1156-1166 |
artikel |
12 |
Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability
|
Bu, Chaojie |
|
|
25 |
5 |
p. 1378-1388 |
artikel |
13 |
High expression of CETN2 is associated with platinum resistance and poor prognosis in epithelial ovarian cancer
|
Qiu, Pei-yuan |
|
|
25 |
5 |
p. 1340-1352 |
artikel |
14 |
HNF4G stimulates the development of pancreatic cancer by promoting IGF2BP2 transcription
|
Zhan, Jian |
|
|
25 |
5 |
p. 1472-1481 |
artikel |
15 |
Hospital-based proton therapy implementation during the COVID pandemic: early clinical and research experience in a European academic institution
|
Calvo, Felipe A. |
|
|
25 |
5 |
p. 1268-1276 |
artikel |
16 |
125I brachytherapy: a useful treatment to control painful osteoblastic bone metastases
|
Liu, Yiming |
|
|
25 |
5 |
p. 1297-1306 |
artikel |
17 |
Immune infiltration could predict the efficacy of short-term radiotherapy in patients with cervical cancer
|
Sun, Zhiqiang |
|
|
25 |
5 |
p. 1353-1367 |
artikel |
18 |
Maintenance of angiogenesis inhibition with aflibercept after progression to bevacizumab in metastatic colorectal cancer: real life study in the Valencian community
|
Raga, Mireia Gil |
|
|
25 |
5 |
p. 1455-1462 |
artikel |
19 |
Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia
|
Ramos Elbal, Eduardo |
|
|
25 |
5 |
p. 1446-1454 |
artikel |
20 |
MicroRNA-452: a double-edged sword in multiple human cancers
|
Karimi Dermani, Fateme |
|
|
25 |
5 |
p. 1189-1206 |
artikel |
21 |
New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
|
Isla, Dolores |
|
|
25 |
5 |
p. 1252-1267 |
artikel |
22 |
PARs in the inflammation-cancer transformation of CRC
|
Lv, Jianyu |
|
|
25 |
5 |
p. 1242-1251 |
artikel |
23 |
PIK3R2 predicts poor outcomes for patients with melanoma and contributes to the malignant progression via PI3K/AKT/NF-κB axis
|
Wang, Jianguo |
|
|
25 |
5 |
p. 1402-1412 |
artikel |
24 |
Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma
|
Houlihan, Orla A. |
|
|
25 |
5 |
p. 1368-1377 |
artikel |
25 |
Prognostic role and clinical significance of tumor-infiltrating lymphocyte (TIL) and programmed death ligand 1 (PD-L1) expression in gastric cancer: a systematic review and meta-analysis
|
Ren, Juan |
|
|
25 |
5 |
p. 1436-1445 |
artikel |
26 |
Radiation pneumonitis in relation to pulmonary function, dosimetric factors, TGFβ1 expression, and quality of life in breast cancer patients receiving post-operative radiotherapy: a prospective 6-month follow-up study
|
Ozgen, Zerrin |
|
|
25 |
5 |
p. 1287-1296 |
artikel |
27 |
Risk and prognosis of secondary breast cancer after radiation therapy for non-Hodgkin lymphoma: a massive population-based analysis
|
Lv, Xiaoyan |
|
|
25 |
5 |
p. 1307-1314 |
artikel |
28 |
siRNA and targeted delivery systems in breast cancer therapy
|
Mirzaei, Sepideh |
|
|
25 |
5 |
p. 1167-1188 |
artikel |
29 |
The multifaced role and therapeutic regulation of autophagy in ovarian cancer
|
Nokhostin, Fahimeh |
|
|
25 |
5 |
p. 1207-1217 |
artikel |
30 |
TIPE1 inhibits the growth of Ewing’s sarcoma cells by suppressing Wnt/β-catenin signaling
|
Wang, Zhichao |
|
|
25 |
5 |
p. 1332-1339 |
artikel |
31 |
Understanding the role of Cripto-1 in cancer progression and therapeutic strategies
|
Zeng, Qingfang |
|
|
25 |
5 |
p. 1135-1144 |
artikel |